Intellectual Property Law

HB Ad Slot
HB Mobile Ad Slot

Intellectual property applies to many different areas of the legal world. Applying for patents for work-products, by individual employees, trademark laws, copyrights, and how companies leverage their IP asset-rights over employees, are just a few of the many areas the National Law Review covers as it pertains to IP.

Intellectual Property Litigation

Intellectual Property disputes are a complex area of law, often involving deep dives into complex concepts to understand the issues at play. In the United States, the United States Patent and Trademark Office (USPTO/PTO) is the agency involved in registering patents and trademarks.   As part of the USPTO, the Patent Trial and Appeal Board settles patent disputes, using a variety of mechanisms to settle issues related to intellectual property.    Some of the mechanisms include inter partes review, post-grant procedures, and covered business method patent reviews.  Issues related to the America Invents Act are also settled through the PTAB. The National Law Review covers changes to standards held by the USPTO in litigation and other patent issues.  The Trademark Trial and Appeal Board settles disputes related to trademarks, such as an ex parte appeal from the denial of an application for registration by an examining attorney, and an inter partes opposition, cancellation, concurrent use, or interference proceeding.  Other agencies involved in patent disputes are the International Trade Commission (ITC) or the Federal Trade Commission (FTC).  The National Law Review covers patent news as it relates to Supreme Court (SCOTUS) and federal circuit courts’ appeals, as well as general patent litigation and new patent filings.

Intellectual Property in Drug Patents

Legal analysis related to drug patents and pharmaceuticals and the interplay with intellectual property issues are also covered by the National Law Review.   Drug patents, biosimilars, generic top-level domain registration (gTLD), trade secrets, non-compete clauses, and other patent application news are updated on the site regularly. Additionally, tangential issues that impact pharmaceutical companies, such as innovator liability and related litigation, are also analyzed by the legal experts who write for the National Law Review. 

Intellectual Property in an Employment Context

The National Law Review has legal analysis on the intersection between intellectual property rights and employment, and who owns ideas, the Work Made For Hire principle as well resulting litigation. Additionally, legislation such as the Defense of Trade Secrets Act and its impact on workplaces, and ongoing litigation related to the legislation is also covered.

International Intellectual Property

Visitors to the site will oftentimes read about international news as it relates to patent applications in the US, and internationally as well. Pharmaceutical patents in Brazil, medical device patent applications from the United Kingdom, or litigation from the European Union, China, India, and other international sectors, are often covered online. Visitors will find the latest coverage, news, and insights on patent applications and litigation, when visiting the National Law Review, for up-to-date practice-area news.

National Law Review Intellectual Property/Patent Law TwitterFor hourly updates on the latest news about Intellectual Property Law, IP Litigation, Patent Legislation, and more, be sure to follow our IP Law Twitter feed, and sign up for complimentary e-news bulletins.

Recent Intellectual Property, Patent, Trademark & Copyright News

Title
Custom text Organization Sort descending
Mar
4
2018
Complex Claim Construction Issues in Knowles Electronics v. Cirrus Logic Schwegman, Lundberg & Woessner, P.A.
Mar
24
2018
Ex parte Bhogal and Ex parte Hoff: PTAB raises burden on USPTO to justify 101 rejections Schwegman, Lundberg & Woessner, P.A.
Nov
17
2022
China’s Supreme People’s Court Releases List of Typical Antitrust (Anti-Monopoly) Cases of People’s Courts Schwegman, Lundberg & Woessner, P.A.
Nov
6
2012
Voter Verified Decision Elaborates on Internet Publication Schwegman, Lundberg & Woessner, P.A.
Jan
12
2023
China’s Supreme People’s Court Releases Second Batch of Typical Civil Code Cases Including Piercing the Corporate Veil in a Trademark/Unfair Competition Case Schwegman, Lundberg & Woessner, P.A.
Jun
11
2018
PTO Issues Section 101 Memorandum after Vanda Decision Schwegman, Lundberg & Woessner, P.A.
Mar
2
2023
China Again Top Originator of International Patent Cooperation Treaty Applications in 2022; China’s Huawei Top Filer in 2022 Schwegman, Lundberg & Woessner, P.A.
Jun
28
2018
Finjan, Inc. v ESET, LLC: Can Billing Records Evidence Intent Element of Inequitable Conduct? Schwegman, Lundberg & Woessner, P.A.
Mar
24
2023
Copyright Registrations Up 1.42% in China YoY for 2022; Software Copyright Registrations Down 19.5% Schwegman, Lundberg & Woessner, P.A.
Sep
13
2018
Ex parte Ho – Burden Shifting in s.101 Rejections Schwegman, Lundberg & Woessner, P.A.
Apr
27
2023
China’s Supreme People’s Court Releases Summaries of 43 Legal Application Issues from 2022 Intellectual Property Cases Schwegman, Lundberg & Woessner, P.A.
Mar
27
2013
Federal Court Affirms Board of Patent Appeals and Interferences (BPAI) in Dawson v. Dawson and Bowman Schwegman, Lundberg & Woessner, P.A.
Nov
9
2018
Kumar v. Iancu – The Dangers of an Overstuffed Preamble/Note on 37 CFR Part 4. Schwegman, Lundberg & Woessner, P.A.
Jun
2
2023
China’s National Intellectual Property Administration to Cease Accepting Trademark Applications from Agencies that Failed to Reregister Schwegman, Lundberg & Woessner, P.A.
Apr
26
2013
Progressive Casualty Litigation Stayed Pending Outcome of Liberty Mutual Covered Business Method Patents Schwegman, Lundberg & Woessner, P.A.
Jun
14
2023
2022 Annual Report of the China National Intellectual Property Administration: 955,000 Patent Applications Were ‘Abnormal’ Schwegman, Lundberg & Woessner, P.A.
May
16
2013
CLS Bank v. Alice Corp. (Part 2) Re: Patent Litigation Schwegman, Lundberg & Woessner, P.A.
Sep
6
2023
China’s National Intellectual Property Administration Releases Typical Cases of Abnormal Patent Applications Schwegman, Lundberg & Woessner, P.A.
Jun
18
2019
Cutting Through the Patent Thicket – The Little Bill that Couldn’t Schwegman, Lundberg & Woessner, P.A.
Nov
4
2013
Synthes v. Spinal Kinetics – When “Structure” is Not Enough Re: Patent Litigation Schwegman, Lundberg & Woessner, P.A.
Nov
11
2013
Ariosa Diagnostics v. Sequenom: Another One Bites The Dust Schwegman, Lundberg & Woessner, P.A.
Dec
23
2023
China’s National Intellectual Property Administration to Allow Third-Party Challenges to Pharmaceutical Patent Term Extensions Schwegman, Lundberg & Woessner, P.A.
Apr
1
2016
Bristol-Myers Squibb v. Merck – Mayo/Alice Rule Reaches Medical Treatment Methods Schwegman, Lundberg & Woessner, P.A.
Apr
11
2016
Genetic Technologies Affirms Ariosa/Myriad With Introduction By Sequenom Petition for Cert. Schwegman, Lundberg & Woessner, P.A.
Jan
29
2024
Is the Patent Eligibility Act a Panacea for Claims to Diagnostics? Schwegman, Lundberg & Woessner, P.A.
Sep
3
2019
INO v. Praxair – Method-by-Selection Claims Fail Mayo/Alice Test Schwegman, Lundberg & Woessner, P.A.
Jan
29
2014
Boiling Down the Logic Behind the CLS Bank Decision Schwegman, Lundberg & Woessner, P.A.
Mar
21
2014
United States Patent & Trademark Office (USPTO) Guidelines Blur “Natural” And “Novel” Products Schwegman, Lundberg & Woessner, P.A.
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins